Equities
Health CarePharmaceuticals & Biotechnology
  • Price (HUF)8,585.00
  • Today's Change-25.00 / -0.29%
  • Shares traded232.34k
  • 1 Year change+30.77%
  • Beta0.5551
Data delayed at least 15 minutes, as of Oct 27 2021 16:05 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.

  • Revenue in HUF (TTM)584.89bn
  • Net income in HUF99.07bn
  • Incorporated1923
  • Employees12.67k
  • Location
    Richter Gedeon Vegyeszeti Gyar NyrtGyomroi ut 19-21.BUDAPEST 1103HungaryHUN
  • Phone+36 14314027
  • Fax+36 12604891
  • Websitehttps://www.richter.hu/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
RICHTER:BUD since
announced
Transaction
value
Janssen Pharmaceutica Nv-Evra Brand Transdermal Contraceptive AssetsAnnounced03 Dec 202003 Dec 2020Announced18.50%263.50m
Data delayed at least 15 minutes, as of Oct 27 2021 16:05 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Laboratorios Farmaceuticos ROVI SA189.48bn30.12bn1.23tn1.50k40.298.2333.876.481.491.499.377.290.87351.095.63365,667.4013.898.4218.1510.8854.6057.8215.909.821.44199.440.152815.0810.1411.2955.4725.2514.8122.36
Virbac SA359.81bn59.53bn1.27tn4.90k21.364.9816.633.5419.3119.31116.7482.870.77862.327.58200,795.6013.153.8818.815.5448.0446.8516.895.691.1246.830.14822.63-0.44161.84166.6670.99-6.15--
Siegfried Holding AG316.11bn15.26bn1.33tn3.43k82.334.7328.284.2210.7810.78221.20187.610.66992.104.21364,878.805.044.366.005.2121.2519.127.526.071.2191.020.246928.011.3911.95-25.12-2.40-6.16--
Krka d.d. Novo Mesto562.28bn112.44bn1.34tn11.61k11.321.818.792.379.859.8549.2261.730.64981.453.52131,863.8012.929.6615.1311.5757.7457.1119.8814.243.1121.710.006458.982.785.6818.5112.96-5.7813.54
ALK-Abello A/S179.28bn2.70bn1.38tn2.47k559.269.3795.567.694.964.96331.07295.990.64881.337.101,492,440.000.9771-0.33171.25-0.396858.6858.941.51-0.53220.83195.000.194--6.636.33150.00-40.812.21--
Financiere de Tubize SA123.86bn122.58bn1.51tn--12.351.19--12.227.547.547.6278.050.1178--42,397.38--11.6610.5311.7310.8099.6998.7598.9799.91----0.0010.03-7.813.72-8.174.16--5.45
AddLife AB277.57bn27.74bn1.52tn1.78k53.8110.5236.515.466.546.5464.9133.451.105.697.866,828,507.0011.04--20.05--35.35--10.03--0.289719.630.5027--51.56--268.28------
Genus plc248.99bn20.51bn1.57tn3.10k76.617.2941.026.320.72060.72068.757.570.6731--5.55185,497.405.493.306.523.85----8.155.211.37--0.233966.724.158.1433.99-0.824912.698.38
Dottikon ES Holding AG74.90bn17.90bn1.60tn639.0079.907.0265.4321.364.184.1817.4947.610.34840.49845.13342,558.708.336.449.257.2179.4682.3223.9017.594.11--0.00--25.2512.5157.7729.6731.33--
Richter Gedeon Vegyeszeti Gyar Nyrt584.89bn99.07bn1.60tn12.67k16.151.9611.252.74533.04533.043,146.364,403.710.60052.213.6645,213,900.0010.316.5611.767.4655.1856.4617.1611.372.0911.130.02939.9411.629.19122.0914.2114.8825.52
Abcam Plc129.07bn7.02bn1.62tn1.50k226.655.8872.3012.530.07260.07261.322.800.3641.986.56--1.986.632.307.6271.1570.225.4413.664.0913.360.1483--14.5011.6429.60-15.4229.70--
H. Lundbeck A/S833.11bn90.67bn1.74tn5.60k19.192.029.872.099.309.3085.4188.270.47651.694.473,015,459.005.198.976.7513.1075.0277.3310.8813.580.657658.630.248149.663.733.90-31.65---30.54--
Dermapharm Holding SE307.98bn45.03bn1.76tn2.36k39.1713.2927.805.712.282.2815.616.730.68021.4311.79364,942.409.8912.1611.2814.7062.3852.6914.5413.221.2321.140.6269--13.2615.5811.1846.5422.26--
Orion Oyj372.44bn68.07bn1.94tn3.34k28.367.1122.725.201.331.337.255.290.94591.676.86308,033.8017.3020.1720.4025.5656.8460.2718.2920.822.14169.640.126997.662.581.209.731.10-1.192.90
BACHEM HOLDING AG158.76bn33.65bn2.02tn1.58k108.4121.8647.2012.727.037.0333.1634.850.64771.246.30314,573.6013.739.0918.5311.6532.9531.0521.2017.500.433530.100.230174.8828.1414.0244.1219.6525.007.63
Data as of Oct 27 2021. Currency figures normalised to Richter Gedeon Vegyeszeti Gyar Nyrt's reporting currency: Hungarian Forint HUF

Institutional shareholders

21.80%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 03 Aug 20219.46m5.08%
Hermes Investment Management Ltd.as of 30 Sep 20215.33m2.86%
Schroder Investment Management Ltd.as of 31 Aug 20214.91m2.64%
The Vanguard Group, Inc.as of 08 Oct 20214.43m2.38%
Templeton Asset Management Ltd.as of 30 Sep 20213.93m2.11%
Invesco Advisers, Inc.as of 31 Aug 20213.24m1.74%
Seafarer Capital Partners LLCas of 30 Jun 20212.89m1.55%
BlackRock Fund Advisorsas of 07 Oct 20212.88m1.55%
Oddo BHF Asset Management SASas of 30 Sep 20211.83m0.98%
Robeco Institutional Asset Management BVas of 31 Aug 20211.72m0.93%
More ▼
Data from 30 Jun 2021 - 30 Sep 2021Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.